AngioConsult GmbH starts the collaboration with LimFlow SA

LimFlow SA initiated commercial cooperation with AngioConsult as an experienced partner in the field of consulting services in the medical device space.

This company offers the first solution of a percutaneous system in the world for arterializing the deep veins of the foot for the treatment of end-stage Critical Limb Ischemia.The LimFlow-system is used when all other treatment options have been exhausted and the CLI patient is indicated for a major amputation of the foot.

By using a percutaneous system, LimFlow SA can promote wound healing, reduce amputations and restore mobility for patients.

This unique system uses proprietary ultrasound-guided catheters and covered nitinol stents to create an arterio-venous channel. These novel products serve to bypass diseased and occluded arteries, to redirect the flow of blood into the tibialis vein and thus revascularize the entire ischemic foot.

"We are proud that we have been able to work with LimFlow SA, one of the most innovative partners in the field of cardiovascular medical products. Not only we benefit from this cooperation, but also the patients will have access -once introduced to the German market- to a new treatment option." said Hanns-Joachim Rieck, CEO of AngioConsult GmbH.

Dan Rose, CEO of LimFlow SA, "We´re absolutely confident in choosing AngioConsult as a partner and we know that they can help us with launching our product in the German market. We are happy to have a partner with great experience at our side and look forward to the upcoming cooperation."
 
The company received CE mark approval for its LimFlow Percutaneous Deep Vein Arterialization (pDVA) system in October 2016. The aim of the cooperation with AngioConsult GmbH is to establish the pDVA procedure on the German market.

About LimFlow SA:
LimFlow SA is a European company founded in 2012 by MD Start, a European start-up incubator. Since August 2016, Dan Rose has been CEO of LimFlow SA. He enriches the company through his 16 years of leadership experience in the field of cardiovascular medical products.

AngioConsult GmbH, headquartered in Speyer, Germany, have more than 20 years of industry experience, which is paired with excellent consulting services in the healthcare sector based on many years of expert know-how. One of the main objectives is to support the customers at every stage of the product life circle.

Angio Consult GmbH
Iggelheimer Str. 26
67346 Speyer
Phone: +49(0) 6232 60 42 890

This release was published on openPR.